UBS Group AG, 10% Owner at ENDRA Life Sciences Inc. (NDRA), bought 3,715 shares at $0.55 ($2K) on 2024-08-27, disclosed to the SEC on 2024-08-29.
Open-market purchase of $2k NDRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| VLCN | BUY | 2024-07-10 | $489 | — | Filing → |
| EDBL | BUY | 2024-05-03 | $6K | — | Filing → |
| EDBL | SELL | 2024-05-03 | $304K | — | Filing → |